Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Clinical trial NCT04038502 · RECRUITING

Trial details

NCT number: NCT04038502
Sponsor: VA Office of Research and Development
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castrate Resistant Prostate Cancer BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 RAD51B, RAD51C, RAD51D, or RAD54L Mutations

Start date: 2019-10-01
Primary completion: 2027-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.